Witzeman Michael D 4
4 · CHEMED CORP · Filed Mar 11, 2025
Insider Transaction Report
Form 4
CHEMED CORPCHE
Witzeman Michael D
VP & Chief Financial Officer
Transactions
- Exercise/Conversion
Stock Option (right to buy with tandem tax withholding)
2025-03-10$445.35/sh−8,796$3,917,299→ 34,484 totalExercise: $445.35Exp: 2026-10-28→ Capital Stock (8,796 underlying) - Exercise/Conversion
Capital Stock
2025-03-10$445.35/sh+8,796$3,917,299→ 13,154 total - Tax Payment
Capital Stock
2025-03-10$600.92/sh−7,494$4,503,294→ 5,660 total
Footnotes (2)
- [F1]Payment of purchase price and tax obligation on stock option exercise.
- [F2]Vesting in three equal annual installments commencing 10/28/2022